The Global Phage Therapy Bridge 2027, organised by PrecisionPhage, is designed to bring together the different parts of this growing field, from clinicians and researchers to phage companies, manufacturers, regulatory experts, technology providers, investors and healthcare professionals. this meeting places a strong emphasis on discussion, networking and practical collaboration. The organisers describe it as a focused international meeting intended to connect complementary expertise and identify opportunities for collaboration in phage therapy.
What Will Be Discussed?
The two-day programme covers some of the practical questions that are becoming increasingly important as phage therapy moves toward clinical application.
Topics include:
- Real-world experience with phage therapy in hospitals
- Technologies and services supporting phage therapy
- Regulatory pathways and personalised phage treatments
- Manufacturing and quality requirements for clinical phage therapy
- Reimbursement, healthcare economics and patient access
- International collaborations and opportunities for joint projects
The programme also includes sessions looking at phage therapy from different regional perspectives, with an emphasis on connecting expertise across Europe, the UK, North America and the Asia-Pacific region.
Who Is This Event For?
The Global Phage Therapy Bridge is intended for people and organisations actively involved in phage therapy or in areas that can help move the field forward.
This includes clinicians, hospitals, phage therapy and biotechnology companies, phage banks, pharmaceutical manufacturers, CDMOs, quality specialists, diagnostic and sequencing providers, bioinformatics and technology companies, regulatory experts, healthcare policy professionals, reimbursement specialists and investors.
